FDA Inspection 856058 — Similasan Corporation
The FDA completed an inspection of Similasan Corporation on November 20, 2013 in Highlands Ranch, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 20, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Highlands Ranch, CO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)